177 related articles for article (PubMed ID: 6720434)
1. Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics.
Jackman AL; Calvert AH; Hart LI; Harrap KR
Adv Exp Med Biol; 1984; 165 Pt B():375-8. PubMed ID: 6720434
[No Abstract] [Full Text] [Related]
2. Quinazoline analogues of folic acid as inhibitors of thymidylate synthetase from bacterial and mammalian sources.
Scanlon KJ; Moroson BA; Bertino JR; Hynes JB
Mol Pharmacol; 1979 Jul; 16(1):261-9. PubMed ID: 113660
[No Abstract] [Full Text] [Related]
3. Plasma nucleoside and base levels following treatment with the new thymidylate synthetase inhibitor CB 3717.
Taylor GA; Jackman AL; Calvert AH; Harrap KR
Adv Exp Med Biol; 1984; 165 Pt B():379-82. PubMed ID: 6720435
[No Abstract] [Full Text] [Related]
4. A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in mice.
Jones TR; Calvert AH; Jackman AL; Brown SJ; Jones M; Harrap KR
Eur J Cancer (1965); 1981 Jan; 17(1):11-9. PubMed ID: 7262141
[No Abstract] [Full Text] [Related]
5. Estimation of the in vitro and in vivo inhibitory effects of antifolates upon thymidylate synthase (TS) in whole cells.
Taylor GA; Jackman AL; Balmanno K; Hughes LR; Calvert AH
Adv Exp Med Biol; 1989; 253B():383-8. PubMed ID: 2610126
[No Abstract] [Full Text] [Related]
6. The duration of the inhibition of thymidylate synthase in intact L1210 cells exposed to two different classes of quinazoline analogues.
Kimbell R; Jackman AL; Boyle FT; Hardcastle A; Aherne W
Adv Exp Med Biol; 1993; 338():597-600. PubMed ID: 8304189
[No Abstract] [Full Text] [Related]
7. Quinazoline folate analogs inhibit the catalytic activity of thymidylate synthase but allow binding of 5-fluorodeoxyuridylate.
Keyomarsi K; Moran RG
J Biol Chem; 1990 Nov; 265(31):19163-9. PubMed ID: 2146271
[TBL] [Abstract][Full Text] [Related]
8. Quinazoline antifolates as inhibitors of growth, dihydrofolate reductase, and thymidylate synthetase of mouse neuroblastoma cells in culture.
Carlin SC; Rosenberg RN; VandeVenter L; Friedkin M
Mol Pharmacol; 1974 Mar; 10(2):194-203. PubMed ID: 4546895
[No Abstract] [Full Text] [Related]
9. Quinazoline antifolate thymidylate synthase inhibitors: 2'-fluoro-N10-propargyl-5,8-dideazafolic acid and derivatives with modifications in the C2 position.
Jackman AL; Marsham PR; Thornton TJ; Bishop JA; O'Connor BM; Hughes LR; Calvert AH; Jones TR
J Med Chem; 1990 Nov; 33(11):3067-71. PubMed ID: 2231607
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and antitumor effects of 5,8-dideazaisopteroylglutamate, a unique quinazoline inhibitor of thymidylate synthase.
Fernandes DJ; Bertino JR; Hynes JB
Cancer Res; 1983 Mar; 43(3):1117-23. PubMed ID: 6825083
[No Abstract] [Full Text] [Related]
11. Multivariate analysis and quantitative structure-activity relationships. Inhibition of dihydrofolate reductase and thymidylate synthetase by quinazolines.
Chen BK; Horváth C; Bertino JR
J Med Chem; 1979 May; 22(5):483-91. PubMed ID: 110930
[TBL] [Abstract][Full Text] [Related]
12. Quinazoline thymidylate synthase inhibitors: methods for assessing the contribution of polyglutamation to their in vitro activity.
Jackman AL; Kimbell R; Brown M; Brunton L; Boyle FT
Anticancer Drug Des; 1995 Oct; 10(7):555-72. PubMed ID: 7495479
[TBL] [Abstract][Full Text] [Related]
13. Activity of the new antifolate N10-propargyl-5,8-dideazafolate and its polyglutamates against human dihydrofolate reductase, human thymidylate synthetase, and KB cells containing different levels of dihydrofolate reductase.
Cheng YC; Dutschman GE; Starnes MC; Fisher MH; Nanavathi NT; Nair MG
Cancer Res; 1985 Feb; 45(2):598-600. PubMed ID: 3917852
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines.
Jackman AL; Kelland LR; Kimbell R; Brown M; Gibson W; Aherne GW; Hardcastle A; Boyle FT
Br J Cancer; 1995 May; 71(5):914-24. PubMed ID: 7537518
[TBL] [Abstract][Full Text] [Related]
15. A convenient procedure for purification of thymidylate synthase from L1210 cells.
Banerjee CK; Bennett LL; Brockman RW; Sani BP; Temple C
Anal Biochem; 1982 Apr; 121(2):275-80. PubMed ID: 7103057
[No Abstract] [Full Text] [Related]
16. Quinoline antifolate thymidylate synthase inhibitors: variation of the C2- and C4-substituents.
Warner P; Barker AJ; Jackman AL; Burrows KD; Roberts N; Bishop JA; O'Connor BM; Hughes LR
J Med Chem; 1992 Jul; 35(15):2761-8. PubMed ID: 1495009
[TBL] [Abstract][Full Text] [Related]
17. Quinazoline antifolate thymidylate synthase inhibitors: replacement of glutamic acid in the C2-methyl series.
Marsham PR; Jackman AL; Barker AJ; Boyle FT; Pegg SJ; Wardleworth JM; Kimbell R; O'Connor BM; Calvert AH; Hughes LR
J Med Chem; 1995 Mar; 38(6):994-1004. PubMed ID: 7699716
[TBL] [Abstract][Full Text] [Related]
18. Quinazoline antifolate thymidylate synthase inhibitors: alkyl, substituted alkyl, and aryl substituents in the C2 position.
Hughes LR; Jackman AL; Oldfield J; Smith RC; Burrows KD; Marsham PR; Bishop JA; Jones TR; O'Connor BM; Calvert AH
J Med Chem; 1990 Nov; 33(11):3060-7. PubMed ID: 2231606
[TBL] [Abstract][Full Text] [Related]
19. Quinazoline antifolates inhibiting thymidylate synthase: variation of the amino acid.
Jones TR; Smithers MJ; Betteridge RF; Taylor MA; Jackman AL; Calvert AH; Davies LC; Harrap KR
J Med Chem; 1986 Jun; 29(6):1114-8. PubMed ID: 3712376
[TBL] [Abstract][Full Text] [Related]
20. Quinazoline antifolates inhibiting thymidylate synthase: 2-desamino derivatives with enhanced solubility and potency.
Jones TR; Thornton TJ; Flinn A; Jackman AL; Newell DR; Calvert AH
J Med Chem; 1989 Apr; 32(4):847-52. PubMed ID: 2704030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
